BBIO - BridgeBio Pharma, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
BridgeBio Pharma, Inc.
IPO Date: June 24, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $13B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.00 | 3.18%
Avg Daily Range (30 D): $1.34 | 1.87%
Avg Daily Range (90 D): $1.37 | 1.81%
Institutional Daily Volume
Avg Daily Volume: 1.56M
Avg Daily Volume (30 D): 2.13M
Avg Daily Volume (90 D): 2.39M
Trade Size
Avg Trade Size (Sh.): 81
Avg Trade Size (Sh.) (30 D): 69
Avg Trade Size (Sh.) (90 D): 74
Institutional Trades
Total Institutional Trades: 10,270
Avg Institutional Trade: $3.63M
Avg Institutional Trade (30 D): $5.35M
Avg Institutional Trade (90 D): $6.42M
Avg Institutional Trade Volume: .09M
Avg Institutional Trades (Per Day): 5
Market Closing Trades
Avg Closing Trade: $9.65M
Avg Closing Trade (30 D): $28.52M
Avg Closing Trade (90 D): $37.14M
Avg Closing Volume: 263.47K
 
News
Oct 7, 2026 @ 2:37 PM
FDA Grants Priority Review to BridgeBio's Dwarfism...
Source: Na
Sep 16, 2026 @ 4:01 PM
BioMarin Stops Voxzogo Development for Noonan Synd...
Source: Na
Sep 3, 2026 @ 4:28 PM
How BioMarin Turned a Competitive Threat Into a Ro...
Source: Zacks.Com
Aug 31, 2026 @ 7:44 PM
BridgeBio Announces Agreement with U.S. Government...
Source: Bridgebio Pharma, Inc.
Aug 14, 2026 @ 3:15 PM
BridgeBio Stock Has Soared 29% in Just 3 Months. H...
Source: Eric Volkman
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-3.56 $-.78 $-.84
Diluted EPS $-3.56 $-.78 $-.84
Revenue $713.07M $243.68M $194.52M
Gross Profit $673.41M $228.63M $184.58M
Net Income / Loss $-702.02M $-155.89M $-166.56M
Operating Income / Loss $-497.8M $-107.08M $-105.96M
Cost of Revenue $39.66M $15.05M $9.94M
Net Cash Flow $-71.06M $-201.98M $309.88M
PE Ratio